Global Blood Therapeutics, Inc. Increase (Decrease) in Accounts Payable, Related Parties
Global Blood Therapeutics, Inc. reported Increase (Decrease) in Accounts Payable, Related Parties of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2018-02-27
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2016-03-31 was $0.00, a 100.00% decline year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2015-12-31 was $0.00.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2015-09-30 was -$12.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for the quarter ending 2015-06-30 was -$41.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for fiscal 2015 was -$14.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for fiscal 2014 was -$115.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in accounts payable, related parties for fiscal 2013 was -$68.00K.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 3 month | Increase (Decrease) in Accounts Payable, Related Parties 6 month | Increase (Decrease) in Accounts Payable, Related Parties 9 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month |
|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-12 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | -$12.00K derived: sum of 3 quarters · filed 2018-02-27 | -$53.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$12.00K derived: sum of 2 quarters · filed 2018-02-27 | -$53.00K derived: sum of 3 quarters · filed 2018-02-27 | -$14.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$53.00K derived: sum of 2 quarters · filed 2015-11-12 | -$14.00K 10-Q · filed 2015-11-12 | -$22.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-09-24 | -$2.00K 10-Q · filed 2015-09-24 | -$10.00K derived: sum of 3 quarters · filed 2017-03-13 | -$120.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $39.00K 10-Q · filed 2016-05-12 | $31.00K derived: sum of 2 quarters · filed 2017-03-13 | -$79.00K derived: sum of 3 quarters · filed 2017-03-13 | |
| 2014-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$118.00K derived: sum of 2 quarters · filed 2017-03-13 | -$115.00K 10-K · filed 2017-03-13 | |
| 2014-09-30 | -$110.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$107.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $3.00K 10-Q · filed 2015-09-24 | |||
| 2013-12-31 | -$68.00K 10-K · filed 2016-03-29 |